Inclusion Criteria:

• Woman, as defined by sex at birth.
• Age 22 years or older at the time of eligibility screening.
• Premenopausal.
• BMI < 40 kg/m^2.
• Unlikely to be pregnant during home scan, based on either current intrauterine device (IUD) or other birth control use or recent menstruation, defined as the home scan occurring between day 3 and 10 of the menstrual cycle based on patient self-report.
• English-speaking and able to follow verbal instructions of the remote ultrasound. technologist as determined by the ability to complete the consent process unassisted.
• Ability to manipulate a 1 lb. weight by hand.
• Residence in state where a PI holds a valid license to practice medicine.
• Ability to receive signature delivery of the investigational ultrasound device.
• Ability to return the investigational ultrasound device by specified instructions.

Exclusion Criteria:

• Pregnant or may be pregnant.
• Has recently given birth, and has had fewer than 3 postpartum menstrual cycles.
• Has recently had a stillbirth or abortion more than 20 weeks (subject to the 3 postpartum menstrual cycles above). Miscarriages or abortions less than 20 weeks are subject to two wait cycles.
• Has changed birth control within the current menstrual cycle (one 'washout' cycle is required).
• Turtle Health employees.
• Has known cancer of a pelvic organ, not currently in remission.
• Not able to schedule a scan while meeting the requirements above prior to the end of the trial. For example, women who change birth control within the last cycle of the trial (and would require a 'washout cycle' that would delay trial close) or who are unable to schedule within the last few weeks of the trial after reasonable scheduling efforts have been made.
• Previous hysterectomy or oophorectomy.
• Does not have one or more of the following anatomic organs: vagina, left ovary, right ovary, or uterus.
• Subjects with prior scanning experience are included in the trial (as they would be in the real world) but excluded from the primary image quality endpoint (due to experience potentially influencing that endpoint) and analyzed separately as a subgroup for that endpoint only. This sub-population is capped at 200 subjects (~20% of trial).

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/14/22. Questions regarding updates should be directed to the study team contact.